Douglas W. Sborov, MD, MS

Languages spoken: English
MyChart

Clinical Locations

  • Dr. Douglas Sborov is an Associate Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He was born and raised in Minnesota, completed his undergraduate education with a Bachelor of Science at the University of Wisconsin-Madison, later completed medical school through American University of the Caribbean, and spent 3 years in Salt Lake City for his internal medicine residency. After almost 5 years in Columbus, OH, completing hematology, oncology, and bone marrow transplantation fellowships, he joined the Division of Hematology to continue his career as a clinical trialist focused on the treatment of patients with hematologic malignancies. Dr. Sborov is the Director of the Multiple Myeloma Program and Division of Hematology Biorepository, member of the Huntsman Cancer Institute Experimental Therapeutics Program, Physician Leader of the Multiple Myeloma/Bone Marrow Transplant arm of the HCI Clinical Trials Office (CTO), active member of the HCI Protocol Review and Monitoring Committee, and he was recently elected as a Huntsman Translational Scholar. Dr. Sborov’s primary research concentration is the development of novel therapeutics for patients with multiple myeloma. His work has been published in various high impact medical journals including Clinical Cancer Research, Oncotarget, Blood, and the British Journal of Haematology. Along with his work developing novel anticancer agents and regimens, Dr. Sborov is working closely with the entire multiple myeloma team to further develop a state-of-the-art clinical trial and research program that offers patients the opportunity to take part in advancing cutting edge, high quality, next generation treatment options.

    Board Certification and Academic Information

    Academic Departments Internal Medicine - Primary
    Academic Divisions

    Patient Rating

    4.9/5

    The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

    Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Learn more about our survey

    Patient Comments

    Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    November 28, 2022

    Dr. Sborov is the Best !

    November 14, 2022

    Okay

    November 12, 2022

    Dr Sborov listens to his patient

    See More Patient Comments

  • Dr. Douglas Sborov is an Associate Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He was born and raised in Minnesota, completed his undergraduate education with a Bachelor of Science at the University of Wisconsin-Madison, later completed medical school through American University of the Caribbean, and spent 3 years in Salt Lake City for his internal medicine residency. After almost 5 years in Columbus, OH, completing hematology, oncology, and bone marrow transplantation fellowships, he joined the Division of Hematology to continue his career as a clinical trialist focused on the treatment of patients with hematologic malignancies. Dr. Sborov is the Director of the Multiple Myeloma Program and Division of Hematology Biorepository, member of the Huntsman Cancer Institute Experimental Therapeutics Program, Physician Leader of the Multiple Myeloma/Bone Marrow Transplant arm of the HCI Clinical Trials Office (CTO), active member of the HCI Protocol Review and Monitoring Committee, and he was recently elected as a Huntsman Translational Scholar. Dr. Sborov’s primary research concentration is the development of novel therapeutics for patients with multiple myeloma. His work has been published in various high impact medical journals including Clinical Cancer Research, Oncotarget, Blood, and the British Journal of Haematology. Along with his work developing novel anticancer agents and regimens, Dr. Sborov is working closely with the entire multiple myeloma team to further develop a state-of-the-art clinical trial and research program that offers patients the opportunity to take part in advancing cutting edge, high quality, next generation treatment options.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions

    Research interests

    Education history

    Fellowship T32 Clinical Research Fellowship - The Ohio State University Clinical Research Fellow
    Medical Science, Translational Medicine - The Ohio State University M.S.
    Fellowship Hematology/Oncology/Bone Marrow Transplantation - The Ohio State University Fellow
    Internal Medicine - University of Utah School of Medicine Resident
    Professional Medical Medicine - American University of the Caribbean School of Medicine M.D.
    Psychology and Zoology - University of Wisconsin-Madison B.S.